There’s new hope for the treatment of Pulmonary Arterial Hypertension (PAH) after scientists from Université Paris-Saclay have discovered a revolutionary way to stop the deterioration of the arteries.

PAH is a fatal lung disease characterised by high blood pressure in the pulmonary arteries that go from the heart to the lung. To treat this some doctors may prescribe medication that may be able to help – see online cialis.

Over time, the small pulmonary arteries become obstructed – a process called vascular remodeling – due to uncontrolled cell production. This causes high pressure and impedes blood flow. As the right side of the heart works harder to pump blood to the lungs, it becomes overloaded, and eventually fails. The prognosis of the disease is globally poor, with sufferers only living on average for three years after diagnosis.

One available treatment for PAH are vasodilators, drugs which relax the muscle in blood vessels, causing the vessels to dilate. Unfortunately, this treatment is not curative and patients are often forced to have lung transplants.

However, innovative scientists from Université Paris-Saclay are now developing a unique new treatment for this deadly disease.